French MPs OK bill raising industry levy and imposing price cuts
This article was originally published in Scrip
The lower house of the French parliament has passed the 2012 social security financing bill (PLFSS), which among other things will increase the sales-based contribution on the pharmaceutical industry, boost the use of generics and impose drug price cuts, as part of a drive to keep healthcare spending within set limits.
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
The UK’s rapid authorization of the Pfizer/BioNTech COVID-19 vaccine has sparked a public debate over regulatory processes at some of the world’s key regulatory bodies.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.